目的:评估新型插管喉罩气道(ILMA)在幕上肿瘤手术后恢复期的安全性和有效性。
方法:2012年1月至2016年12月在我们中心接受幕上肿瘤手术的患者符合这项前瞻性随机分组的条件。平行组研究。我们使用紧密配合的喉罩开发了一种新型ILMA(编号:4/5),带7.0/7.5毫米气管内导管(ETT)加螺钉固定器和防污染套管。
结果:总计,100例患者用新型ILMA和100例ETT插管。组间血流动力学变量没有差异,氧饱和度,呼出二氧化碳或脑电双频指数均在72小时恢复期间记录。然而,咳嗽的发生率明显减少,与ETT组相比,ILMA组的液体引流较少,手术液中的血红蛋白水平较低.
结论:我们的新型ILMA装置与咳嗽减少有关,幕上肿瘤手术后恢复期手术引流中的液体引流和血液。
OBJECTIVE: To assess safety and efficacy of a novel intubation laryngeal mask airway (ILMA) during the recovery period following supratentorial tumour surgery.
METHODS: Patients who underwent supratentorial tumour surgery at our centre from January 2012 to December 2016 were eligible for this prospective randomised, parallel group study. We developed a novel ILMA using closely fitting laryngeal masks (No. 4/5) with 7.0/7.5 mm endotracheal tubes (ETT) plus screw fixators and anti-pollution sleeves.
RESULTS: In total, 100 patients were intubated with the novel ILMA and 100 the ETT. There were no differences between groups in haemodynamic variables, oxygen saturation, exhaled CO2, or bispectral index all recorded during the 72-hour recovery period. However, there were significantly fewer incidences of coughing, less fluid drainage and lower haemoglobin levels in surgical fluid in the ILMA group compared with the ETT group.
CONCLUSIONS: Our novel ILMA device was associated with reduced coughing, fluid drainage and blood in surgical drain during the recovery period following supratentorial tumour surgery.